top of page

Two posters, highlighting HaemaLogiX results, will be presented at International Myeloma Society, Athens

Laptop On Tray_edited_edited_edited.jpg

31 August 2023

HaemaLogiX is pleased to announce the acceptance of two abstracts for poster presentation at the annual International Myeloma Society Meeting and Exposition,  to be held in Athens 27-30 September, 2023.

On 27 September,  2023, Prof. Simon Harrison, Director of the Centre of Excellence in Cellular Immunotherapy at the Peter MacCallum Cancer Centre, will present the poster ‘A Novel CAR-T cell therapy targeting kappa myeloma antigen for the treatment of multiple myeloma’.

Also, see recent announcement: HaemaLogiX to take KMA.CAR-T to Ph 1 trial with Peter Mac.

On 28 September, 2023, HaemaLogiX Chief Scientific Officer Dr Rosanne Dunn will present the abstract ‘Novel antigens LMA and KMA are expressed on malignant bone marrow plasma cells from patients at all stages of multiple myeloma and in other plasma cell dyscrasias’.

Links to the abstracts and posters will be available on our website, after the event.

bottom of page